Weiland O - Search Results

1

Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study.

Pradat P, Alberti A, Poynard T, Esteban JI, Weiland O, Marcellin P, Badalamenti S, Trépo C. Pradat P, et al. Among authors: weiland o. Hepatology. 2002 Oct;36(4 Pt 1):973-7. doi: 10.1053/jhep.2002.35530. Hepatology. 2002. PMID: 12297846

2

Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.

Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palù G, Reiss P, Thiebaut R, Weiland O, Yazdanpanah Y, Zeuzem S; ECC Jury. Alberti A, et al. Among authors: weiland o. J Hepatol. 2005 May;42(5):615-24. doi: 10.1016/j.jhep.2005.03.003. J Hepatol. 2005. PMID: 15916745 Review. No abstract available.

3

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

Schalm SW, Hansen BE, Chemello L, Bellobuono A, Brouwer JT, Weiland O, Cavalletto L, Schvarcz R, Ideo G, Alberti A. Schalm SW, et al. Among authors: weiland o. J Hepatol. 1997 May;26(5):961-6. doi: 10.1016/s0168-8278(97)80103-1. J Hepatol. 1997. PMID: 9186825

4

Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.

Rico MA, Quiroga JA, Subirá D, Garcia E, Castañón S, Sällberg M, Leroux-Roels G, Weiland O, Pardo M, Carreño V. Rico MA, et al. Among authors: weiland o. J Hepatol. 2002 Mar;36(3):408-16. doi: 10.1016/s0168-8278(01)00281-1. J Hepatol. 2002. PMID: 11867186

5

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment.

Reichard O, Glaumann H, Frydén A, Norkrans G, Schvarcz R, Sönnerborg A, Yun ZB, Weiland O. Reichard O, et al. Among authors: weiland o. Hepatology. 1995 Apr;21(4):918-22. Hepatology. 1995. PMID: 7705800

6

Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related Outcomes.

Kamal H, Westman G, Falconer K, Duberg AS, Weiland O, Haverinen S, Wejstål R, Carlsson T, Kampmann C, Larsson SB, Björkman P, Nystedt A, Cardell K, Svensson S, Stenmark S, Wedemeyer H, Aleman S. Kamal H, et al. Among authors: weiland o. Hepatology. 2020 Oct;72(4):1177-1190. doi: 10.1002/hep.31214. Epub 2020 Sep 24. Hepatology. 2020. PMID: 32145073

7

Interferon-ribavirin combination therapy for chronic hepatitis C.

Schalm SW, Brouwer JT, Chemello L, Alberti A, Bellobuono A, Ideo G, Schwartz R, Weiland O. Schalm SW, et al. Among authors: weiland o. Dig Dis Sci. 1996 Dec;41(12 Suppl):131S-134S. doi: 10.1007/BF02087889. Dig Dis Sci. 1996. PMID: 9011471

8

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.

van der Meer AJ, Feld JJ, Hofer H, Almasio PL, Calvaruso V, Fernández-Rodríguez CM, Aleman S, Ganne-Carrié N, D'Ambrosio R, Pol S, Trapero-Marugan M, Maan R, Moreno-Otero R, Mallet V, Hultcrantz R, Weiland O, Rutter K, Di Marco V, Alonso S, Bruno S, Colombo M, de Knegt RJ, Veldt BJ, Hansen BE, Janssen HLA. van der Meer AJ, et al. Among authors: weiland o. J Hepatol. 2017 Mar;66(3):485-493. doi: 10.1016/j.jhep.2016.10.017. Epub 2016 Oct 22. J Hepatol. 2017. PMID: 27780714

9

High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.

Reichard O, Foberg U, Frydén A, Mattsson L, Norkrans G, Sönnerborg A, Wejstål R, Yun ZB, Weiland O. Reichard O, et al. Among authors: weiland o. Hepatology. 1994 Feb;19(2):280-5. Hepatology. 1994. PMID: 7507462 Clinical Trial.

10

Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon.

Reichard O, Glaumann H, Frydén A, Norkrans G, Wejstål R, Weiland O. Reichard O, et al. Among authors: weiland o. J Hepatol. 1999 May;30(5):783-7. doi: 10.1016/s0168-8278(99)80129-9. J Hepatol. 1999. PMID: 10365802 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters